Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...
We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...
Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI ...
As AI tools like OpenAI’s GPT-5.5 and Anthropic’s Claude Design expand capabilities in coding and visual creation, experts warn of a homogenization of ideas and loss of creative distinction. Studies ...
As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...
At the start of Ben Lerner's startling new novel "Transcription," a man sits on a train trying to read and failing because he ...
The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...
In a first-of-its-kind finding, researchers at University of Iowa Health Care discovered that specific genetic sequences have ...
AI is forcing a measurement crisis we’ve avoided for 100 years. If AI can write our emails, analyze data, and generate code, ...
QClaw 's international beta opened with a number that sounds like footnote material until you think about what it implies: 99 ...
The current problem with DeFi is that the organic demand for on-chain credit, borrowing to fund productive economic activity, ...
Swapping paramours, hobbies, and physical features to meet the pop-culture moment, the Kardashians both shape and reflect the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results